 SAN DIEGO, Calif., Sept. 07, 2021 GLOBE NEWSWIRE -- Maravai LifeSciences Holdings, Inc. Maravai NASDAQ: MRVI, a global provider of life science reagents and services to researchers and biotech innovators, today announced the commencement of a public offering of its Class A common stock by certain selling stockholders. The selling stockholders are offering 20,000,000 shares of Maravais Class A common stock pursuant to a registration statement on Form S-1 the Registration Statement filed with the Securities and Exchange Commission the SEC. The selling stockholders intend to grant the underwriters a 30-day option to purchase up to an additional 3,000,000 shares of Maravais Class A common stock. 